Integrin inhibitor and uses thereof
US12018025B2 · kind B2 · utility
1Cited by
12References
163Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2021 |
| Grant date | Jun 25, 2024 |
| Priority date | — |
| Expiry date | Nov 19, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are integrin inhibitors, compositions thereof, and methods of their uses. Crystalline forms of salts of the inhibitors are also described, along with methods of preparing the crystalline forms. X-ray powder diffraction data, thermogravimetric analysis, and differential scanning calorimetry data are provided for the crystalline forms. The integrin inhibitors are useful for treatment of, inter alia, fibrotic diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.